Preferencias y satisfacción hacia un programa de tamizaje con pruebas autoadministradas de deteccion del virus de papiloma humano

Abstract

RESUMENEstudio transversal que describe preferencias y satisfacción hacia un programa de tamizaje de cáncer cervical con pruebas rápidas autoadministradas, para la detección del virus de papiloma humano (VPH). De las 2090 usuarias captadas por el programa en Ventanilla Callao-Perú, se seleccionó aleatoriamente a 97 para ser encuestadas. Asimismo, se realizaron entrevistas a mujeres líderes de la comunidad, encargadas de ofrecer las pruebas. El 74,2% de las usuarias se sintió, cuanto menos, satisfecha con el programa. El 68% de las mujeres prefiere la autotoma de la prueba, principalmente por demandar menos tiempo. De las mujeres que prefieren la toma en el centro de salud, el 90,3% lo hace por la seguridad de que la prueba sea realizada correctamente. La inclusión de líderes comunitarias en el programa permitió una buena difusión de la prueba y de los pasos para realizarla. PREFERENCES AND SATISFACTION TOWARDS A SCREENING PROGRAM WITH SELF-ADMINISTERED HUMAN PAPILLOMA VIRUS DETECTION TESTS ABSTRACTCross-sectional study describing preferences and satisfaction towards a cervical cancer screening program with selfadministered rapid tests for the detection of human papillomavirus (HPV). Of 2 090 users picked by the program in Ventanilla Callao -Peru, 97 were randomly selected to be surveyed. In addition, interviews were conducted with women leaders of the community, in charge of providing the evidence. 74.2% of the users felt, at least, satisfied with the program. 68% of women prefer to take the test, mainly by demanding less time. Of women who prefer to take the test at the Health Center, 90.3% do so for the safety of the test being done correctly. The inclusion of community leaders in the program allowed a good diffusion of the test and the steps to carry it out.

Policy Considerations to Promote Equitable Cervical Cancer Screening and Treatment in Peru

“…Another innovation, the use of a self-sampling molecular HPV test, aims to overcome the challenges of accessing a clinic and the gynecological examination. A study testing this methodology found that 74.2 percent of women were satisfied with the HPV self-sampling, women received their results using SMS messages to their cell phones, and 97 percent reported they would like to participate again in such a screening program [ 36 ]. Another community-based innovation is HOPE Peru, which trains women from communities where women at highest risk of cervical cancer reside to promote HPV self-testing, educate women about cervical cancer prevention, screening, and treatment, and refer HPV positive women to health centers.…”

“…• Technological innovations [1,29,36,[45][46][47] • No comprehensive system for evaluation of these innovations [17,33,34] • Create system for evaluation, accountability, and implementation…”

Eliminating Deaths From Cervical Cancer—Report of a Panel at the 7th Annual Symposium on Global Cancer Research, a Satellite Meeting at the Consortium of Universities for Global Health 10th Annual Meeting

“…8-10 LA also is pioneering the implementation of new models for cervical cancer screening, introducing HPV testing and self-sampling. 11-14 However, among the biggest challenges in HPV and cervical cancer research in LA are the scarce global funding opportunities directed toward the region and the relatively little research funding from national governments. In the global space, LA is not seen necessarily as a region in which to invest in research, denying not only the needs the region has but also the opportunities LA offers, because funding could be catalytic for meaningful research and result in excellent examples for other countries in the global south of what could be achieved and how to do it.…”

“…Some countries in LA have started with success in HPV testing with and without self-collection, involving community health agents. 12-14,18 HPV self-collection could help achieve a high coverage for screening, which, together with other new technologies like thermocoagulation for treatment, 19,20 could provide the opportunity to control and eliminate cervical cancer in LA.…”

Detección del virus del papiloma humano en muestras obtenidas mediante técnica de autotoma en un grupo de universitarias peruanas

“…Si bien la sensibilidad y especificidad de la prueba del VPH con muestras vaginales colectadas por autotoma es menor en comparación con las muestras cervicales tomadas por el personal de salud, sus valores son aceptables (8) . En el Perú, se estudió la preferencia y satisfacción de 97 usuarias respecto a un programa de tamizaje con pruebas que utilizan la autotoma para la detección del VPH, obteniendo que un 68,8% prefirieron esta alternativa, por la menor demanda de tiempo y mayor privacidad como las principales razones de preferencia (9) . No obstante, la inseguridad que la prueba se realice correctamente fue el motivo para que las mujeres opten por la asistencia del personal de salud.…”